JP Morgan, AbbVie vet takes helm at Amgen-partnered neuroscience startup


A 20-year veteran of JP Morgan who went on to become AbbVie's chief strategy officer is now making the leap to early-stage biotech.

Previous Stock Yards Bank opening Mason banking branch
Next Renovated ER alleviates strain on Boston hospitals to serve minorities farther from city center